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Nosocomial bacterial meningitis may result from inva-
sive procedures (for examples, such as craniotomies, the 
placement of internal or external ventricular catheters, 
lumbar puncture, intrathecal infusions of medications, 
or spinal anesthesia), head trauma, or hospital-acquired 
bacteremia complicated by metastatic infection [1]. The 
specific bacteria that cause nosocomial meningitis vary 
according to the pathogenesis and timing of infection 
after the predisposing event, so the choice of empirical 
antimicrobial therapy depends on the pathogenesis of the 
infection. In particular, the antimicrobial susceptibility 
profiles for locally common gram negative bacilli must be 
considered in the approach to empirical therapy [2]. How-
ever, there has been no report of nosocomial meningitis in 
Korea, apart from a number of case series.
In this issue of the Korean J Intern Med, Kim et al. [3] 
described the epidemiology of nosocomial meningitis and 
its outcomes. They reported that the most common or-
ganisms by rank were coagulase-negative staphylococci, 
Acinetobacter species, and Staphylococcus aureus. Most 
(78/91, 86%) of the infections were related to the place-
ment of an external ventricular drain (EVD).
In the recent literature, the incidence of EVD-related 
infections ranges from 2% to 27% [4]. In Korea, the re-
ported rate of surgical site infection (SSI) was 3.09-3.68 
per 100 operations in nationwide prospective multicenter 
studies of craniotomy in 2008 and 2009 [5,6]. While the 
incidence of EVD-related infections and the SSI rates after 
craniotomy in Kim et al. [3]. were not given, the preven-
tion of EVD-related ventriculomeningitis is of paramount 
importance because it is a significant cause of morbidity 
and mortality in critically ill neurological patients. Rel-
evant risk factors have been identified as the duration of 
catheterization, frequency of EVD manipulation, intra-
ventricular hemorrhage, and insertion techniques [4]. 
Therefore, the avoidance of modifiable risk factors should 
be emphasized.
Acinetobacter species are nosocomial pathogens of 
increasing importance, even in post-neurosurgical menin-
gitis, with mortality from this infection exceeding 15% [7]. 
Alarmingly, Acinetobacter was the second most common 
cause of nosocomial meningitis in this study. In fact, Aci-
netobacter can survive in a wide range of environments 
and persist for extended periods of time on surfaces, which 
m ake it a frequent cause of outbreaks of infection and an 
endemic, healthcare-associated pathogen [8]. Acineto-
bacter is easily transmitted via direct contact with colo-
nized patients or the hands of hospital staff, and even by 
respiratory droplets. Furthermore, antimicrobial therapy 
for these pathogens has become problematic, as they are 
frequently resistant to expanded-spectrum cephalosporins 
and carbapenems. Given the emergence of carbapenem-
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resistant Acinetobacter species, the therapeutic options 
are limited and no optimal treatment has been established 
[9]. Consistent with these findings, Kim et al. [3] reported 
that 26% of Acinetobacter species were resistant to imi-
penem and 27% of the patients infected with them died. 
Therefore, infection-control measures should be enforced 
vigorously to prevent person-to-person spread and cross-
infection from the environment.
In conclusion, nosocomial bacterial meningitis poses a 
substantial challenge because of the emergence of disease 
caused by multidrug resistant organisms (MDROs) and 
severely limited treatment options. Encouraged by recent 
progress in reducing the incidence of infections associated 
with invasive devices, we should now turn our attention to 
preventing and controlling infection due to MDROs. The 
time is right to make effective prevention the new status 
quo.
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